Why is Chemcrux Enterprises Ltd falling/rising?

Recent Price Movement and Market Context

On the day in question, Chemcrux’s stock outperformed its sector by 1.65%, reaching an intraday high of ₹106.40, a 2.75% increase from its previous close. However, the weighted average price indicates that a larger volume of shares traded closer to the day’s low, suggesting some selling pressure amid the rally. The stock currently trades just 4.58% above its 52-week low of ₹100, signalling that it remains near its lowest valuation range over the past year.

Technical indicators show the stock price is above its 5-day moving average but remains below longer-term averages such as the 20-day, 50-day, 100-day, and 200-day moving averages. This pattern reflects a short-term positive momentum that has yet to translate into a sustained recovery.

Investor participation has notably increased, with delivery volumes on 12 Jan rising by 71.83% compared to the five-day average, indicating heightened interest in the stock despite its recent struggles. Liquidity remains adequate for trading, supporting the stock’s accessibility to investors.

Long-Term Performance and Valuation Challenges

Despite the recent uptick, Chemcrux’s long-term performance paints a more concerning picture. Over the past year, the stock has declined by 32.10%, significantly underperforming the Sensex, which gained 9.56% during the same period. The underperformance extends further back, with a three-year loss of 70.97% compared to a 38.78% gain in the benchmark index. Even over five years, the stock’s 27.03% return lags well behind the Sensex’s 68.97% appreciation.

Operationally, the company has struggled with declining sales and profitability. Net sales have contracted at an annual rate of 13.89% over the last five years, while operating profit has fallen by 42.95%. The most recent quarterly results reflect this trend, with profit before tax less other income registering a loss of ₹0.23 crore, a steep decline of 117.69%. Return on capital employed (ROCE) remains low, at 4.2% for the company and 6.37% for the half-year period, indicating limited efficiency in generating returns from capital investments.

Nonetheless, Chemcrux maintains a relatively strong balance sheet with a low Debt to EBITDA ratio of 1.30 times, suggesting a manageable debt burden and capacity to service liabilities. The stock’s enterprise value to capital employed ratio of 1.9 also points to a fair valuation, trading at a discount compared to its peers’ historical averages.

Investor Sentiment and Outlook

The recent price rise appears to be driven by short-term factors such as increased investor participation and a slight rebound from near 52-week lows. However, the company’s fundamental challenges, including poor long-term growth, declining profitability, and consistent underperformance against broader market indices, continue to weigh heavily on sentiment.

Majority ownership by promoters may provide some stability, but the flat results reported in September 2025 and ongoing operational headwinds suggest that investors remain cautious. The stock’s inability to keep pace with the BSE500 index over the last three years further underscores the need for a more robust turnaround before sustained gains can be expected.

Conclusion

Chemcrux Enterprises Ltd’s modest price rise on 13-Jan reflects a short-term rebound amid increased trading activity and a slight outperformance relative to its sector. However, the company’s persistent long-term challenges, including declining sales, shrinking profits, and consistent underperformance against market benchmarks, continue to overshadow this positive movement. Investors should weigh the stock’s fair valuation and manageable debt levels against its weak growth trajectory and operational setbacks before considering exposure.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →